March 11, 2021

Peggy Lillis Foundation for C. diff Education & Advocacy (PLF), the leading patient organization combating C. difficile infections (CDI), partners with Ferring Pharmaceuticals through a new sponsorship to help fund new and existing patient advocacy initiatives. Joining forces, PLF and Ferring are eager to continue helping people living with CDI …

March 23, 2020

The Food and Drug Administration (FDA) issued a Safety Alert today Regarding Use of Fecal Microbiota for Transplantation and Additional Safety Protections Pertaining to COVID-19. According to the alert, “FDA is informing health care providers and patients of the potential risk of transmission of SARS-CoV-2 virus by the use of fecal …

March 15, 2020

On March 12, the Food and Drug Administration (FDA) issued a safety alert that eight patients were infected following fecal microbiota transplants (FMT) using material from a company which was later confirmed to be OpenBiome, an independent stool bank. Two of the patients subsequently died. FDA did not name OpenBiome …

December 17, 2019

PLF Board members Christina Fuhrman and Dr. Bruce Hirsch are featured in this story on healthline.com. She Recovered from a C. diff Infection, Then Her Daughter Got It Too Three months before her wedding in 2012, Christina Fuhrman was hospitalized due to severe diarrhea. “The day I started feeling sick, …

December 2, 2019

PLF’s Rhode Island-based Advocate Megan Mimnaugh wrote an op-ed for the Providence Journal highlighting our “See C. diff” campaign. Read it below: My Turn: Meghan Mimnaugh: Americans should know about deadly infection Losing a loved one is always painful. It’s particularly excruciating when their death was preventable. Before my mom …